M. Battiwalla

发表

Impact of pre‐transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation

W. Wood, M. Aljurf, J. Szer, 2017, Cancer.

Late Cardiovascular Morbidity and Mortality Following Pediatric Allogeneic Hematopoietic Cell Transplantation

B. Shaw, M. Flowers, Paul L Martin, 2018, Bone Marrow Transplantation.

K. Cornetta, S. Braun, M. Battiwalla, 1997, Molecular medicine today.

Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse after Hematopoietic Stem Cell Transplantation: part II. Autologous Transplantation-novel agents and immunomodulatory strategies.

N. Kröger, P. Hari, M. Bishop, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HLA-C antigen mismatch is associated with worse outcome in unrelated donor peripheral blood stem cell transplantation.

J. Klein, Stephanie J. Lee, O. Ringdén, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Relapse after allogeneic stem cell transplantation

A. Barrett, M. Battiwalla, A. Barrett, 2010, Expert review of hematology.

Risk factors for the development of cutaneous melanoma after allogeneic hematopoietic cell transplantation.

M. Tucker, B. Shaw, M. Flowers, 2018, Journal of the American Academy of Dermatology.

The impact of early versus late tocilizumab administration in patients with cytokine release syndrome secondary to immune effector cell therapy

I. Flinn, M. Battiwalla, W. Donnellan, 2021, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Safety Issues in MSC Therapy

A. Barrett, M. Battiwalla, 2013 .

Risk of acute myeloid leukemia and myelodysplastic syndrome after autotransplants for lymphomas and plasma cell myeloma.

J. Fay, W. Wood, J. Maciejewski, 2018, Leukemia research.

Age no bar: A CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma

P. Hari, J. Zaucha, M. Krem, 2020, Cancer.

Neighborhood-Poverty and Pediatric Allogeneic Hematopoietic Cell Transplantation Outcomes: A CIBMTR Analysis.

W. Wood, M. Aljurf, A. Yoshimi, 2020, Blood.

Persistence of Pseudomonas aeruginosa in a pulmonary nodule with late relapse

R. Danner, A. Barrett, J. Dekker, 2014, Transplant infectious disease : an official journal of the Transplantation Society.

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Consensus Recommendations for Cardiovascular Disease and Associated Risk Factors

L. Jones, A. Remaley, Marcus Y. Chen, 2017 .

Allogeneic hematopoietic cell transplantation for fanconi anemia in patients with pretransplantation cytogenetic abnormalities, myelodysplastic syndrome, or acute leukemia.

H. Deeg, E. Guinan, B. George, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A comparison of measured creatinine clearance versus calculated glomerular filtration rate for assessment of renal function before autologous and allogeneic BMT.

P. McCarthy, T. Hahn, M. Battiwalla, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Optimal donor for African Americans with hematologic malignancy: HLA-haploidentical relative or umbilical cord blood transplant.

K. Ballen, O. Ringdén, D. Rizzieri, 2020, Biology of Blood and Marrow Transplantation.

Ocular surface indicators and biomarkers in chronic ocular graft-versus-host disease: a prospective cohort study

F. Ferris, R. Childs, J. Barrett, 2021, Bone Marrow Transplantation.

Quantitative activation suppression assay to evaluate human bone marrow-derived mesenchymal stromal cell potency.

K. Keyvanfar, P. Hanley, A. Barrett, 2015, Cytotherapy.

Heat shock protein 90 regulates the expression of Wilms tumor 1 protein in myeloid leukemias.

D. Proia, K. Foley, F. Giles, 2010, Blood.

A Practical Guide to Gynecologic and Reproductive Health in Women Undergoing Hematopoietic Stem Cell Transplant.

P. Stratton, M. Battiwalla, Jeanne Murphy, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cytoreduction with gemtuzumab ozogamicin and cytarabine prior to allogeneic stem cell transplant for relapsed/refractory acute myeloid leukemia

G. Wilding, P. Wallace, P. McCarthy, 2012, Leukemia & lymphoma.

A multigene array for measurable residual disease detection in AML patients undergoing SCT

C. Hourigan, A. Barrett, N. Hensel, 2015, Bone Marrow Transplantation.

High prevalence of early-onset osteopenia/osteoporosis after allogeneic stem cell transplantation and improvement after bisphosphonate therapy

P. McCarthy, T. Hahn, M. Battiwalla, 2008, Bone Marrow Transplantation.

Contrast enhanced cardiac CT reveals coronary artery disease in 45% of asymptomatic allo-SCT long-term survivors

C. Hourigan, A. Barrett, S. Shanbhag, 2014, Bone Marrow Transplantation.

Female long-term survivors after allogeneic hematopoietic stem cell transplantation: evaluation and management.

P. Stratton, M. Merideth, M. Battiwalla, 2012, Seminars in hematology.

Impact of autologous blood transfusion after bone marrow harvest on unrelated donor’s health and outcome: a CIBMTR analysis

M. Norkin, J. Wingard, J. Liesveld, 2020, Bone Marrow Transplantation.

Clinical and Biological Predictors of Outcome Following Relapse of Chronic Myeloid Leukemia after Allogeneic Stem Cell Transplantation

K. Rezvani, P. Muranski, K. Keyvanfar, 2014, Bone marrow transplantation.

Filgrastim support in allogeneic HSCT for myeloid malignancies: a review of the role of G-CSF and the implications for current practice

M. Battiwalla, P. McCarthy, 2009, Bone Marrow Transplantation.

Cardiovascular risk factors

M. Battiwalla, K. Doucette, 2021, Blood and Marrow Transplantation Long Term Management.

A deletion polymorphism in glutathione-S-transferase mu (GSTM1) and/or theta (GSTT1) is associated with an increased risk of toxicity after autologous blood and marrow transplantation.

C. Ambrosone, L. Sucheston, P. McCarthy, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reversible cardiotoxicity with tyrosine kinase inhibitors.

M. Ahluwalia, P. McCarthy, M. Wetzler, 2010, Clinical advances in hematology & oncology : H&O.

Ultra-low dose interleukin-2 promotes immune-modulating function of regulatory T cells and natural killer cells in healthy volunteers.

Thomas E. Hughes, F. Marincola, Y. Kotliarov, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

Donor lymphocyte count and thymic activity predict lymphocyte recovery and outcomes after matched-sibling hematopoietic stem cell transplant

J. Melenhorst, A. Barrett, N. Hensel, 2013, Haematologica.

Fatal diffuse alveolar hemorrhage associated with sirolimus after allogeneic hematopoietic cell transplantation

P. McCarthy, T. Hahn, M. Battiwalla, 2010, Bone Marrow Transplantation.

HLA Mismatch Is Associated with Worse Outcomes after Unrelated Donor Reduced-Intensity Conditioning Hematopoietic Cell Transplantation: An Analysis from the Center for International Blood and Marrow Transplant Research.

M. Aljurf, J. Pidala, Stephanie J. Lee, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk-associations between HLA-DPB1 T cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent from HLA-DPA1

D. Miklos, Stephanie J. Lee, M. Heemskerk, 2014, Bone Marrow Transplantation.

Amino acid substitution at peptide-binding pockets of HLA class I molecules increases risk of severe acute GVHD and mortality.

J. Pidala, S. Santarone, Stephanie J. Lee, 2013, Blood.

Management of Cytopenias During Treatment with Lenalidomide in Patients with Myelodysplastic Syndromes

R. Wells, M. Battiwalla, 2010 .

Immune Deficits in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients

M. Battiwalla, M. A. Mir, 2009, Mycopathologia.

Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad-spectrum antifungal agents and diagnostic adjuncts.

J. Perfect, J. Wingard, T. Walsh, 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Immunotherapy for fungal infections.

S. Holland, L. Romani, T. Walsh, 2006, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Non-Graft-versus-Host Disease Ocular Complications after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European S

M. Aljurf, R. Gale, N. Callander, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT

M. Aljurf, R. Gale, N. Callander, 2019, Bone Marrow Transplantation.

Bone Marrow‐Derived Mesenchymal Stromal Cells Harness Purinergenic Signaling to Tolerize Human Th1 Cells In Vivo

M. Sabatino, A. Barrett, A. Laurence, 2015, Stem cells.

Pre-existing invasive fungal infection is not a contraindication for allogeneic HSCT for patients with hematologic malignancies: a CIBMTR® study

E. Guinan, M. Boeckh, M. Aljurf, 2016, Bone Marrow Transplantation.

CMV reactivation is associated with a lower incidence of relapse after allo-SCT for CML

G. Fahle, A. Barrett, R. Childs, 2013, Bone Marrow Transplantation.

Clinical and biological predictors of outcome following relapse of CML post-allo-SCT

P. Muranski, K. Keyvanfar, C. Hourigan, 2015, Bone Marrow Transplantation.

Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis

B. Sandmaier, M. Aljurf, R. Gale, 2016, Cancer.

HLA‐DR4 predicts haematological response to cyclosporine in T‐large granular lymphocyte lymphoproliferative disorders

N. Young, A. Barrett, Y. Saunthararajah, 2003, British journal of haematology.

Acquired RhD mosaicism identifies fibrotic transformation of thrombopoietin receptor‐mutated essential thrombocythemia

A. Barrett, M. Albitar, H. Klein, 2017, Transfusion.

The impact of HLA unidirectional mismatches on the outcome of myeloablative hematopoietic stem cell transplantation with unrelated donors.

M. Aljurf, J. Pidala, Stephanie J. Lee, 2013, Blood.

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Developing Recommendations to Improve Survivorship and Long-Term Outcomes.

S. Pavletic, S. Hashmi, N. Majhail, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk factors for the development of cutaneous melanoma after allogeneic hematopoietic cell transplantation.

M. Tucker, B. Shaw, M. Flowers, 2018, Journal of the American Academy of Dermatology.

Mesenchymal Stromal Cells and the Approach to Clinical Trial Design: Lessons Learned From Graft Versus Host Disease

A. Barrett, M. Battiwalla, N. Dunavin, 2017 .

Bone marrow mesenchymal stromal cells to treat complications following allogeneic stem cell transplantation.

A. Barrett, M. Battiwalla, 2014, Tissue engineering. Part B, Reviews.

Comment on Middeke et al , page 2960 Abnl ( 17 p ) in AML : who will guard the guardian ?

M. Battiwalla, 2014 .

Comment on Middeke Et Al, Page 2960

M. Battiwalla, 2014 .

Premature coronary artery disease following allogeneic stem cell transplantation: an NHLBI Cohort Study

Marcus Y. Chen, J. Barrett, M. Battiwalla, 2018, Bone Marrow Transplantation.

Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients

C. Craddock, V. Brown, C. Hourigan, 2022, Leukemia.

Multiparameter flow cytometry for the diagnosis and monitoring of small GPI‐deficient cellular populations

M. Ahluwalia, P. Wallace, P. Starostik, 2010, Cytometry. Part B, Clinical cytometry.

Impact of Baseline Renal Function on Transfusion-Independence Response, Survival, and Transformation to Acute Myeloid Leukemia in Patients with Deletion 5q: A Sub-Analysis of the MDS-003 Study

A. List, M. Battiwalla, R. Knight, 2008 .

Impact of Age on Transfusion Independence Response, Survival, and Transformation to Acute Myeloid Leukemia in Patients with Deletion 5q: A Sub-Analysis of the MDS-003 Study

A. List, M. Battiwalla, R. Knight, 2008 .

REVIEW Mesenchymal stem cells in hematopoietic stem cell transplantation

P. Hematti, M. Battiwalla, 2009 .

Second Allogeneic Hematopoietic Cell Transplantation for Patients with Fanconi Anemia and Bone Marrow Failure.

H. Deeg, J. Wagner, R. Gale, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Human leukocyte antigen (HLA) DR15 is associated with reduced incidence of acute GVHD in HLA-matched allogeneic transplantation but does not impact chronic GVHD incidence.

A. Barrett, P. McCarthy, T. Hahn, 2006, Blood.

Simultaneous presentation of acute monoblastic leukemia and mantle cell lymphoma: Case report and review of the literature

P. Wallace, S. Sait, M. Wetzler, 2005, Leukemia & lymphoma.

HLA DR15 antigen status does not impact graft-versus-host disease or survival in HLA-matched sibling transplantation for hematologic malignancies.

M. Aljurf, B. George, M. Flowers, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Cellular immune profiling after sequential clofarabine and lenalidomide for high risk myelodysplastic syndromes and acute myeloid leukemia

P. Muranski, K. Keyvanfar, A. Barrett, 2017, Leukemia research reports.

Intensive conditioning regimen of etoposide (VP-16), cyclophosphamide and carmustine (VCB) followed by autologous hematopoietic stem cell transplantation for relapsed and refractory Hodgkin's lymphoma

M. Czuczman, F. Hernandez-Ilizaliturri, P. McCarthy, 2008, Bone Marrow Transplantation.

Long-term use of oral beclomethasone dipropionate for the treatment of gastrointestinal graft-versus-host disease.

P. McCarthy, B. Bambach, R. Iyer, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT

H. Greinix, Z. DeFilipp, D. Kelly, 2018, Bone Marrow Transplantation.

Characteristics of Late Fatal Infections after Allogeneic Hematopoietic Cell Transplantation.

M. Norkin, M. Aljurf, J. Wingard, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The clinical and financial burden of pre-emptive management of cytomegalovirus disease after allogeneic stem cell transplantation-implications for preventative treatment approaches.

P. Muranski, C. Hourigan, A. Barrett, 2014, Cytotherapy.

The Clinical and Financial Burden of Preemptive Management of CMV Disease after Allogeneic Stem Cell Transplantation – Implications for Preventative Treatment Approaches

P. Muranski, R. Childs, J. Barrett, 2014 .

Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis.

M. Norkin, A. Barrett, M. Boeckh, 2016, Blood.

Adenosine Selectively Depletes Alloreactive T Cells to Prevent GVHD While Conserving Immunity to Viruses and Leukemia.

P. Muranski, K. Keyvanfar, A. Barrett, 2016, Molecular therapy : the journal of the American Society of Gene Therapy.

T Cell Exhaustion and Downregulation of Cytotoxic NK Cells – an Immune Escape Mechanism in Adult Acute Lymphoblastic Leukemia

P. Muranski, K. Keyvanfar, C. Hourigan, 2014 .

Comorbidity Measures In Ex Vivo T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation (HCT)

A. Barrett, M. Battiwalla, X. Tian, 2013 .

Second Hematopoietic Stem Cell Transplantation for Leukemia Relapsing after Myeloablative T Cell Depleted Transplants Does Not Prolong Survival

A. Barrett, N. Hensel, M. Battiwalla, 2013, Bone Marrow Transplantation.

Allogeneic transplantation using non-myeloablative transplant regimens.

J. Barrett, M. Battiwalla, John Barrett, 2001, Best practice & research. Clinical haematology.

Acute myeloid leukemia and diabetes insipidus with monosomy 7.

G. Wilding, S. Sait, M. Wetzler, 2009, Cancer genetics and cytogenetics.

Male survivors of allogeneic hematopoietic stem cell transplantation have a long term persisting risk of cardiovascular events.

C. Hourigan, A. Barrett, S. Shanbhag, 2014, Experimental hematology.

Successful treatment of disseminated fusariosis with posaconazole during neutropenia and subsequent allogeneic hematopoietic stem cell transplantation

B. Bambach, A. Varma, J. Kwon-Chung, 2007, Transplant infectious disease : an official journal of the Transplantation Society.

Pulmonary Histoplasma Infection After Allogeneic Hematopoietic Stem Cell Transplantation: Case Report and Review of the Literature

G. Fahle, A. Zelazny, J. Barrett, 2017, Open forum infectious diseases.

Modulation of Immune Function

M. Battiwalla, B. Segal, N. Almyroudis, 2009 .

Chapter 9 Modulation of Immune Function

M. Battiwalla, B. Segal, N. Almyroudis, 2009 .

Reprint of: Long-Term Survivorship after Hematopoietic Cell Transplantation: Roadmap for Research and Care.

A. Tichelli, N. Majhail, M. Battiwalla, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-Term Survivorship after Hematopoietic Cell Transplantation: Roadmap for Research and Care.

A. Tichelli, N. Majhail, M. Battiwalla, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Ganciclovir inhibits lymphocyte proliferation by impairing DNA synthesis.

P. Wallace, P. McCarthy, T. Hahn, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Leflunomide failure to control recurrent cytomegalovirus infection in the setting of renal failure after allogeneic stem cell transplantation

M. Battiwalla, B. Segal, N. Almyroudis, 2007, Transplant infectious disease : an official journal of the Transplantation Society.

Human leukocyte antigen DR4 is associated with inferior progression-free survival following allogeneic hematopoietic stem cell transplantation for lymphoid malignancies

P. McCarthy, T. Hahn, C. Aggarwal, 2008, Leukemia & lymphoma.

Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma: a CIBMTR analysis

L. Lekakis, N. Ghosh, H. Lazarus, 2019, Journal of Hematology & Oncology.

Antibody induced coagulopathy from bovine thrombin use during partial nephrectomy.

M. Walther, C. Pavlovich, M. Battiwalla, 2001, The Journal of urology.

Myelodysplastic syndromes.

C. Bloomfield, M. Millenson, H. Deeg, 2011, Journal of the National Comprehensive Cancer Network : JNCCN.

Association of squamous cell carcinoma of the oral cavity in allogeneic hematopoietic stem cell transplant recipients

P. McCarthy, T. Hahn, M. Battiwalla, 2007, Bone Marrow Transplantation.

D. Landau, Catherine J. Wu, N. Kröger, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Epigenetic landscape of the TERT promoter: a potential biomarker for high risk AML/MDS

B. Dumitriu, K. Rezvani, Xingmin Feng, 2016, British journal of haematology.

Mesenchymal stem cells in hematopoietic stem cell transplantation.

Peiman Hematti, P. Hematti, M. Battiwalla, 2009, Cytotherapy.

T-cell large granular lymphocytosis associated with malignant thymoma.

P. Wallace, T. Khoury, M. Battiwalla, 2012, Leukemia research.

Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.

Tao Wang, Thomas Spitzer, Daniel J Weisdorf, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Conservative management of neurocysticercosis in a patient with hematopoietic stem cell transplantation: a case report and review

B. Dumitriu, D. Hammoud, J. Barrett, 2015, Transplant infectious disease : an official journal of the Transplantation Society.

Active thrombopoiesis is associated with worse severity and activity of chronic GVHD

S. Steinberg, A. Barrett, K. Calvo, 2013, Bone Marrow Transplantation.

Excellent Overall Survival and Low Incidence of Late Effects in Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Sickle Cell Disease: A Report from the Center for International Blood and Marrow Transplant Research (CIBMTR)

B. Shaw, L. Krishnamurti, R. Phelan, 2019, Blood.

Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignancies.

A. Barrett, D. Stroncek, R. Childs, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Alemtuzumab in T-cell large granular lymphocytic leukaemia: a phase 2 study

M. Raffeld, B. Dumitriu, Xingmin Feng, 2015, The Lancet. Haematology.

Identification of a permissible HLA mismatch in hematopoietic stem cell transplantation.

M. Aljurf, Stephanie J. Lee, S. Marsh, 2014, Blood.

Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States.

W. Wood, M. Sorror, F. Baron, 2017, Blood.

A Rare Consequence of Chronic Graft Versus Host Disease - Peyronie's Disease.

A. Barrett, Dhruv Kumar, M. Battiwalla, 2015, Archives in cancer research.

Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission.

B. Sandmaier, M. Aljurf, R. Gale, 2019, Blood advances.

Ex vivo T-cell-depleted allogeneic stem cell transplantation for hematologic malignancies: The search for an optimum transplant T-cell dose and T-cell add-back strategy.

P. Muranski, A. Barrett, N. Hensel, 2017, Cytotherapy.

Immune reconstitution in recipients of photodepleted HLA-identical sibling donor stem cell transplantations: T cell subset frequencies predict outcome.

J. Melenhorst, A. Barrett, G. Weber, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Immune Response Following Quadrivalent Human Papillomavirus Vaccination in Women After Hematopoietic Allogeneic Stem Cell Transplant: A Nonrandomized Clinical Trial.

W. Quint, Sarah Wagner, M. Schiffman, 2020, JAMA oncology.

HLA-matched sibling transplantation for severe aplastic anemia: impact of HLA DR15 antigen status on engraftment, graft-versus-host disease, and overall survival.

H. Deeg, B. George, J. Passweg, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Human herpes 6 virus encephalitis complicating allogeneic hematopoietic stem cell transplantation

G. Fahle, A. Nath, A. Freeman, 2013, Neurology.

Clinical comorbidity predictive measures in ex vivo T-cell-depleted allogeneic hematopoietic stem cell transplantation

C. Hourigan, A. Barrett, M. Battiwalla, 2015, Bone Marrow Transplantation.

Minor ABO Incompatibility Does Not Impact Nonrelapse Mortality in T Cell-Depleted Human Leukocyte Antigen-Matched Sibling Transplantation.

J. Barrett, M. Battiwalla, N. Dunavin, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Evaluation of Human Leukocyte Antigen (HLA) Matching Requirements for Unrelated Peripheral Blood Stem Cell (PBSC) Transplantation

J. Klein, Stephanie J. Lee, O. Ringdén, 2008 .

Distinct Biomarker Profiles in Ex Vivo T Cell Depletion Graft Manipulation Strategies: CD34+ Selection versus CD3+/19+ Depletion in Matched Sibling Allogeneic Peripheral Blood Stem Cell Transplantation.

P. Muranski, K. Keyvanfar, A. Barrett, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hematopoietic cell transplantation in human immunodeficiency virus-positive patients with hematologic disorders: a report from the center for international blood and marrow transplant research.

H. Atkins, M. Horowitz, P. Tiberghien, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Persisting posttransplantation cytomegalovirus antigenemia correlates with poor lymphocyte proliferation to cytomegalovirus antigen and predicts for increased late relapse and treatment failure.

D. Follmann, A. Barrett, N. Hensel, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT

M. Norkin, W. Wood, J. Snowden, 2016, Bone Marrow Transplantation.

Persistence of skewed X-chromosome inactivation in pre-B acute lymphoblastic leukemia of a female ATRX mutation carrier.

K. Oetjen, A. Barrett, R. Gibbons, 2019, Blood advances.

Impact of KIR and HLA Genotypes on Outcomes after Reduced-Intensity Conditioning Hematopoietic Cell Transplantation.

K. Hsu, Stephanie J. Lee, O. Ringdén, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse After Hematopoietic Stem Cell Transplantation: part III. Prevention and treatment of relapse after allogeneic transplantation.

N. Kröger, D. Porter, M. Bishop, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risks factors and timing of genital human papillomavirus (HPV) infection in female stem cell transplant survivors: a longitudinal study

A. Barrett, P. Stratton, M. Merideth, 2018, Bone Marrow Transplantation.

Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report

J. Mehta, M. Perales, N. Saba, 2019, Clinical Cancer Research.

Over-expression of PD-1 Does Not Predict Leukemic Relapse after Allogeneic Stem Cell Transplantation.

P. Muranski, K. Keyvanfar, A. Barrett, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Seeing what's out of sight: wireless capsule endoscopy's unique ability to visualize and accurately assess the severity of gastrointestinal graft-versus-host-disease.

P. McCarthy, T. Hahn, M. Battiwalla, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Genetics of HLA Peptide Presentation and Impact on Outcomes in HLA-Matched Allogeneic Hematopoietic Cell Transplantation

V. Brown, B. Vincent, D. Miklos, 2021, Transplantation and Cellular Therapy.

Long‐term outcomes among 2‐year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b‐cell lymphoma

W. Wood, Z. DeFilipp, B. Shaw, 2018, Cancer.

Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia.

J. Liesveld, Z. DeFilipp, B. Shaw, 2020, Blood advances.

Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT

M. Norkin, A. Nagler, J. Szer, 2018, Bone Marrow Transplantation.

Fatal hyperacute graft-versus-host disease following denileukin diftitox treatment for recurrent t cell lymphoma after allogeneic stem cell transplantation.

R. Cheney, G. Deeb, P. McCarthy, 2009, Biology of Blood and Marrow Transplantation.

Upsetting the apple CAR‐T (chimeric antigen receptor T‐cell therapy) ‐ sustainability mandates USA innovation

M. Battiwalla, J. Pantin, 2020, British journal of haematology.

Outcomes of Medicare-age eligible NHL patients receiving RIC allogeneic transplantation: a CIBMTR analysis.

Sonali M. Smith, Z. DeFilipp, H. Lazarus, 2018, Blood advances.

Expression of putative targets of immunotherapy in acute myeloid leukemia and healthy tissues

M. Goswami, C. Hourigan, A. Barrett, 2014, Leukemia.

Impact of early CMV reactivation in cord blood stem cell recipients in the current era

M. Boeckh, J. Wingard, H. Lazarus, 2016, Bone Marrow Transplantation.

Cytomegalovirus Infection Incidence and Risk Factors Across Diverse Hematopoietic Cell Transplantation Platforms Using a Standardized Monitoring and Treatment Approach: A Comprehensive Evaluation from a Single Institution.

A. Barrett, T. Fry, J. Tisdale, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Radiation exposure from diagnostic procedures following allogeneic stem cell transplantation – How much is acceptable?

F. Fakhrejahani, J. Barrett, M. Battiwalla, 2014, Hematology.

Impact of Early Cytomegalovirus Reactivation in Cord Blood Stem Cell Recipients in the Current Era

Riches, M. Boeckh, H. Lazarus, 2016 .

High angiopoietin-2 and suppression of tumorigenicity-2 levels correlate with onset of sinusoidal obstructive syndrome—implication for the utility of serial biomarker monitoring

P. Muranski, A. Barrett, D. Kleiner, 2017, Bone Marrow Transplantation.

Improved reproducibility and quality of GvHD biomarker assay: application of multiplex microfluidic channel system

P. Muranski, A. Barrett, S. Paczesny, 2016, Bone Marrow Transplantation.

Evolution of the donor T-cell repertoire in recipients in the second decade after allogeneic stem cell transplantation.

D. Douek, B. Hill, K. Keyvanfar, 2011, Blood.

Outcomes of Allogeneic Hematopoietic Cell Transplantation in T-cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research.

J Wagner, F. Awan, M. Krem, 2022, Transplantation and cellular therapy.

Framingham Risk Score Is an Ineffective Screening Strategy for Coronary Heart Disease in Long-Term Allogeneic Hematopoietic Cell Transplant Survivors

A. Barrett, Marcus Y. Chen, R. Childs, 2020, Clinical hematology international.

Improved survival after acute graft-versus-host disease diagnosis in the modern era

Alan M. Miller, R. Vij, W. Wood, 2017, Haematologica.

Risk Factors for Subsequent Central Nervous System Tumors in Pediatric Allogeneic Hematopoietic Cell Transplant: A Study from the Center for International Blood and Marrow Transplant Research (CIBMTR).

H. Sengeløv, Chi-kong Li, B. Shaw, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

CD34+ selection and the severity of oropharyngeal mucositis in total body irradiation-based allogeneic stem cell transplantation

M. Sabatino, C. Hourigan, A. Barrett, 2016, Supportive Care in Cancer.

Metabolic syndrome and cardiovascular disease following hematopoietic cell transplantation: screening and preventive practice recommendations from CIBMTR and EBMT

Hamadani, M. Norkin, W. Wood, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Very Early Adoptive Transfer of Ex Vivo Generated Multi-Virus Specific T Cells Is a Safe Strategy for Prevention of Viral Infection after Allogeneic T Cell Depleted Stem Cell Transplantation

M. Sabatino, P. Muranski, A. Barrett, 2018, Blood.

Recombinant human factor VIIa for alveolar hemorrhage following allogeneic stem cell transplantation.

D. Mollura, U. Bagci, Brent Foster, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Abnl(17p) in AML: who will guard the guardian?

M. Battiwalla, 2014, Blood.

Myelodysplastic syndrome evolving from aplastic anemia treated with immunosuppressive therapy: efficacy of hematopoietic stem cell transplantation

H. Deeg, J. Kurtzberg, M. Ayas, 2014, Haematologica.

National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Cardiovascular Disease and Associated Risk Factors Working Group Report.

L. Jones, A. Remaley, Marcus Y. Chen, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of Age.

M. Aljurf, L. Diller, R. Gale, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis

F. Baron, M. Krem, C. Hourigan, 2021, Bone Marrow Transplantation.

Survival outcomes of allogeneic hematopoietic cell transplants with EBV‐positive or EBV‐negative post‐transplant lymphoproliferative disorder, A CIBMTR study

P. Hari, V. Brown, H. Heslop, 2019, Transplant infectious disease : an official journal of the Transplantation Society.

When the Minimal Becomes Measurable.

M. Goswami, Catherine Lai, C. Hourigan, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and matched unrelated donors.

B. George, M. Grunwald, D. Weisdorf, 2021, Blood advances.

Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study.

M. Raffeld, B. Dumitriu, Xingmin Feng, 2016, The Lancet. Haematology.

Factors influencing the late phase of recovery after bone mineral density loss in allogeneic stem cell transplantation survivors

J. Barrett, M. Battiwalla, B. Savani, 2016, Bone Marrow Transplantation.

Accelerated bone mineral density loss occurs with similar incidence and severity, but with different risk factors, after autologous versus allogeneic hematopoietic cell transplantation.

P. McCarthy, T. Hahn, M. Battiwalla, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States.

M. Krem, Stephanie J. Lee, K. Syrjala, 2021, Transplantation and cellular therapy.

Survivorship Issues: Practices, Guidelines and Controversies

S. Hashmi, M. Battiwalla, 2020 .

Title: Impact of Induction Therapy with VRD vs. VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell Transplantation.

Shaji K. Kumar, M. Aljurf, M. Qazilbash, 2021, Transplantation and cellular therapy.

Novel alternative for treating paroxysmal nocturnal hemoglobinuria in selected patients

M. Battiwalla, 2008 .

Dapsone-induced methemoglobinemia after hematopoietic stem cell transplantation.

P. McCarthy, T. Hahn, M. Battiwalla, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Repair of impaired pulmonary function is possible in very-long-term allogeneic stem cell transplantation survivors.

C. Hourigan, A. Barrett, M. Battiwalla, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-term stability of a patient-convenient 1 mg/ml suspension of tacrolimus for accurate maintenance of stable therapeutic levels

P. McCarthy, T. Hahn, M. Battiwalla, 2006, Bone Marrow Transplantation.

Bone Marrow Mesenchymal Stromal Cells to Treat Tissue Damage in Allogeneic Stem Cell Transplant Recipients: Correlation of Biological Markers with Clinical Responses

M. Sabatino, Xingmin Feng, J. Melenhorst, 2014, Stem cells.

Reality check: Real-world evidence to support therapeutic development in hematologic malignancies.

H. Lazarus, M. Battiwalla, M. Hamadani, 2022, Blood reviews.

Impact of second primary malignancy post–autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis

Shaji K. Kumar, M. Aljurf, Y. Nieto, 2023, Blood advances.

Two cases of hepatic zygomycosis in allogeneic stem cell transplant recipients and review of literature

T. Hahn, M. Battiwalla, S. Padmanabhan, 2007, Transplant Infectious Disease.

Immunogenicity of HPV Quadrivalent Vaccine in Women after Allogeneic HCT is Comparable to Healthy Volunteers

A. Barrett, J. Tisdale, R. Childs, 2018 .